Resources

Find the latest news about Femasys, including our media mentions, scientific publications, and more.

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

Innovation in Women’s Reproductive Health is More Important than Ever

Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

Femasys secures CE mark certification for FemVue MINI solution

Providing Safe and Accessible Options for Women’s Reproductive Care

Femasys Creates Products and Procedures for the Fallopian Tubes

Advancements in Technologies Changing Reproductive Healthcare with Kathy Lee-Sepsick

Femasys Inc: Putting the Focus on Women’s Reproductive Health

Femasys: Revolutionizing Female Reproduction (NASDAQ:FEMY)

Anne Morrissey Joins Femasys as a New Board Member to Help Advance FEMASEED into Clinical Development

Women’s Health Company Femasys Files for $40M IPO

Femasys Targets Male Infertility with Updated Trial Design

Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement

Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs

Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control

Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team

Tech Companies Working On Contraception Face A New Landscape After Roe

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

FemCerv®: Well-designed technology that can minimize patient discomfort

The Post-Roe Fertility Journey

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

Innovation in Women’s Reproductive Health is More Important than Ever

Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

Femasys secures CE mark certification for FemVue MINI solution

Providing Safe and Accessible Options for Women’s Reproductive Care

VIDEO: President and CEO, Kathy Lee-Sepsick speaks to connecting with the audience

VIDEO: President and CEO, Kathy Lee-Sepsick at SLS

VIDEO: Femasys KOL Event

Media Kits

For additional information, please email [email protected]